secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001628280-25-030804
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive shareholders elect two Class I directors, approve say-on-pay, ratify KPMG at 2025 annual meeting
--------------------------------------------------------------------------------

- Daniel Barber and Timothy E. Morris elected as Class I directors with 36,060,882 and 35,562,599 votes for, respectively.
- Non-binding advisory vote on executive compensation approved: 32,454,278 for, 6,694,084 against, 459,188 abstain.
- Ratification of KPMG as independent auditor for FY 2025 passed: 66,530,646 for, 1,166,766 against.
- Broker non-votes of 29,848,112 on director elections and say-on-pay proposal.
- Annual Meeting held June 11, 2025; results reported under Item 5.07.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/0001628280-25-030804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/aqst-20250611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-030804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer